Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Reina Ozeki-Hayashi, Misao Fujita, Atsushi Tsuchiya, Taichi Hatta, Eisuke Nakazawa, Yoshiyuki Takimoto & Akira Akabayashi. (2019) Beliefs held by breast surgeons that impact the treatment decision process for advanced breast cancer patients: a qualitative study. Breast Cancer: Targets and Therapy 11, pages 221-229.
Read now
Read now
Malin Anshushaug, Mari Aas Gynnild, Stein Kaasa, Anne Kvikstad & Bjørn H. Grønberg. (2015) Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway. Acta Oncologica 54:3, pages 395-402.
Read now
Read now
Gunnar Steineck & Bengt Glimelius. (2013) What is the appropriate use of palliative docetaxel in castration-resistant prostate cancer?. Acta Oncologica 52:8, pages 1589-1592.
Read now
Read now
Articles from other publishers (16)
Teresa Geyer, Nguyen-Son Le, Iris Groissenberger, Franziska Jutz, Lisa Tschurlovich & Gudrun Kreye. (2023) Systemic Anticancer Treatment Near the End of Life: a Narrative Literature Review. Current Treatment Options in Oncology.
Crossref
Crossref
Indryas Woldie, Tarek Elfiki, Swati Kulkarni, Colvin Springer, Eric McArthur & Nicole Freeman. (2022) Chemotherapy during the last 30 days of life and the role of palliative care referral, a single center experience. BMC Palliative Care 21:1.
Crossref
Crossref
Semiha Urvay, Burak Civelek, Ersin Özaslan & Aziz Ahmet Sürel. (2020) Chemotherapy at the End of Life. Journal of Palliative Care 36:2, pages 73-77.
Crossref
Crossref
Lola-Jade Palmieri, Olivier Dubreuil, Jean-Baptiste Bachet, Isabelle Trouilloud, Christophe Locher, Romain Coriat, Frederick Moryoussef, Bruno Landi, Géraldine Perkins, Vincent Hautefeuille & Solène Doat. (2021) Reasons for chemotherapy discontinuation and end-of-life in patients with gastrointestinal cancer: A multicenter prospective AGEO study. Clinics and Research in Hepatology and Gastroenterology 45:1, pages 101431.
Crossref
Crossref
Elham Akhlaghi, Rebecca H. Lehto, Mohsen Torabikhah, Hamid Sharif Nia, Ahmad Taheri, Ehsan Zaboli & Ameneh Yaghoobzadeh. (2020) Chemotherapy use and quality of life in cancer patients at the end of life: an integrative review. Health and Quality of Life Outcomes 18:1.
Crossref
Crossref
Tae-Kyu Jang, Dae-Yeon Kim, Shin-Wha Lee, Jeong-Yeol Park, Dae-Shik Suh, Jong-Hyeok Kim, Yong-Man Kim, Young-Tak Kim & Joo-Hyun Nam. (2018) Trends in treatment during the last stages of life in end-stage gynecologic cancer patients who received active palliative chemotherapy: a comparative analysis of 10-year data in a single institution. BMC Palliative Care 17:1.
Crossref
Crossref
Yingming Zhu, Ke Tang, Fen Zhao, Yuanwei Zang, Xiaodong Wang, Zhenxiang Li, Xindong Sun & Jinming Yu. (2018) End-of-life chemotherapy is associated with poor survival and aggressive care in patients with small cell lung cancer. Journal of Cancer Research and Clinical Oncology 144:8, pages 1591-1599.
Crossref
Crossref
Hsin-Yun Tsai, Kuo-Piao Chung & Raymond Nien-Chen Kuo. (2018) Impact of Targeted Therapy on the Quality of End-of-Life Care for Patients With Non–Small-Cell Lung Cancer: A Population-Based Study in Taiwan. Journal of Pain and Symptom Management 55:3, pages 798-807.e4.
Crossref
Crossref
Daniel LowEmily C. MerkelManoj MenonGary H. LymanHenry DdunguElizabeth NamukwayaMhoira LengCorey Casper. (2017) Chemotherapy Use at the End of Life in Uganda. Journal of Global Oncology 3:6, pages 711-719.
Crossref
Crossref
Huei-Kai Huang, Jyh-Gang Hsieh, Chia-Jung Hsieh & Ying-Wei Wang. (2017) Do cancer patients with dementia receive less aggressive treatment in end-of-life care? A nationwide population-based cohort study. Oncotarget 8:38, pages 63596-63604.
Crossref
Crossref
P. Rochigneux, J.L. Raoul, Y. Beaussant, R. Aubry, F. Goldwasser, C. Tournigand & L. Morin. (2017) Use of chemotherapy near the end of life: what factors matter?. Annals of Oncology 28:4, pages 809-817.
Crossref
Crossref
Lucas Morin, Yvan Beaussant, Régis Aubry, Johan Fastbom & Kristina Johnell. (2016) Aggressiveness of End-of-Life Care for Hospitalized Individuals with Cancer with and without Dementia: A Nationwide Matched-Cohort Study in France. Journal of the American Geriatrics Society 64:9, pages 1851-1857.
Crossref
Crossref
I. Gallais Sérézal, Y. Beaussant, P. Rochigneux, C. Tournigand, R. Aubry, B. Lindelöf & L. Morin. (2016) End-of-life care for hospitalized patients with metastatic melanoma in France: a nationwide, register-based study. British Journal of Dermatology 175:3, pages 583-592.
Crossref
Crossref
Hee Seung Lee, Kyeong Hyeon Chun, Dochang Moon, Hahn Kyu yeon, Sanghoon Lee & SooHyeon Lee. (2015) Trends in receiving chemotherapy for advanced cancer patients at the end of life. BMC Palliative Care 14:1.
Crossref
Crossref
G. Clarke, S. Johnston, P. Corrie, I. Kuhn & S. Barclay. (2015) Withdrawal of anticancer therapy in advanced disease: a systematic literature review. BMC Cancer 15:1.
Crossref
Crossref
Sema Sezgin Goksu, Seyda Gunduz, Dilek Unal, Mukremin Uysal, Deniz Arslan, Ali M Tatlı, Hakan Bozcuk, Mustafa Ozdogan & Hasan S Coskun. (2014) Use of chemotherapy at the end of life in Turkey. BMC Palliative Care 13:1.
Crossref
Crossref